drugset / Trial / NCT00237666
Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression
Phase 4
Completed
30 enrolled
The Medical Research Network
Liebowitz, Michael R., M.D. · collabPfizer · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the antidepressant effectiveness of Geodon for the treatment of patients diagnosed with Bipolar II disorder who are currently experiencing a major depressive episode.
Timeline
- Start
- 2005-02
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ziprasidone | Small molecule | 20 mg | Oral |
| Subject | Ziprasidone | Small molecule | 60 mg | Oral |